Letko, Brosseau & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Letko, Brosseau & Associates’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.88M	Sell	30,825 -2,000	-6%	-$270K	0.07%	73
2026 Q1	$4.19M	Hold	32,825	–	–	0.07%	68
2025 Q4	$3.7M	Sell	32,825 -2,500	-7%	-$287K	0.06%	68
2025 Q3	$3.54M	Sell	35,325 -3,000	-8%	-$270K	0.06%	68
2025 Q2	$3.18M	Sell	38,325 -1,675	-4%	-$134K	0.06%	68
2025 Q1	$3.24M	Sell	40,000 -2,950	-7%	-$264K	0.07%	67
2024 Q4	$3.87M	Sell	42,950 -5,000	-10%	-$484K	0.07%	70
2024 Q3	$4.74M	Sell	47,950 -8,950	-16%	-$879K	0.09%	72
2024 Q2	$5.28M	Sell	56,900 -8,900	-14%	-$798K	0.1%	74
2024 Q1	$6.24M	Hold	65,800	–	–	0.11%	74
2023 Q4	$5.88M	Hold	65,800	–	–	0.11%	72
2023 Q3	$4.8M	Sell	65,800 -4,500	-6%	-$359K	0.09%	73
2023 Q2	$5.85M	Sell	70,300 -7,200	-9%	-$602K	0.11%	72
2023 Q1	$5.91M	Sell	77,500 -500	-0.6%	-$41.5K	0.11%	74
2022 Q4	$6.47M	Buy	+78,000	New	+$6.31M	0.12%	79

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Letko, Brosseau & Associates's XBI Position: Q2 2026 in Review

Letko, Brosseau & Associates reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 6.1% in Q2 2026, selling an estimated $270K and leaving 30,825 shares worth $4.88M. The position accounts for 0.07% of the portfolio, ranked #73.

Letko, Brosseau & Associates first reported a position in XBI in Q4 2022 and has held it in 15 quarters since. The position peaked at $6.47M in Q4 2022. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Letko, Brosseau & Associates held 30,825 shares of State Street SPDR S&P Biotech ETF worth $4.88M as of Q2 2026.
Letko, Brosseau & Associates sold 2,000 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $270K.
State Street SPDR S&P Biotech ETF made up 0.07% of Letko, Brosseau & Associates's portfolio in Q2 2026, its #73 holding.
Letko, Brosseau & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and has held it in 15 quarters since.
Letko, Brosseau & Associates's State Street SPDR S&P Biotech ETF position peaked at $6.47M in Q4 2022.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2026, filed 13 Aug 2026.